Gene · 2829
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples. | Nat Commun | 2022 | 36433939 | PubTator, text mining | PubMed |
| Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity. | Nat Commun | 2022 | 36418317 | PubTator, text mining | PubMed |
| Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies. | Cell Immunol | 2022 | 36402002 | PubTator, text mining | PubMed |
| CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy. | Sci Adv | 2022 | 36399563 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer. | Front Immunol | 2022 | 36389835 | PubTator, text mining | PubMed |
| Gene variants in pro-coagulant and anti-coagulant genes could be prognostic genetic markers of COVID-19 susceptibility. | Heliyon | 2022 | 36387492 | PubTator, text mining | PubMed |
| Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β. | Mol Ther Methods Clin Dev | 2022 | 36381305 | PubTator, text mining | PubMed |
| To kill or not to kill - The role of the tumor microenvironment in shaping group 1 ILC functions. | Semin Immunol | 2022 | 36372017 | PubTator, text mining | PubMed |
| Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients. | Nat Commun | 2022 | 36357424 | PubTator, text mining | PubMed |
| Genome-wide screening of sex-biased genetic variants potentially associated with COVID-19 hospitalization. | Front Genet | 2022 | 36353114 | PubTator, text mining | PubMed |
| A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination. | Sci Rep | 2022 | 36351985 | PubTator, text mining | PubMed |
| The intracellular cation channel TMEM176B as a dual immunoregulator. | Front Cell Dev Biol | 2022 | 36340035 | PubTator, text mining | PubMed |
| Resistant starch type-4 intake alters circulating bile acids in human subjects. | Front Nutr | 2022 | 36337613 | PubTator, text mining | PubMed |
| Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies. | J Immunother Cancer | 2022 | 36323431 | PubTator, text mining | PubMed |
| NF kappa B regulator Bcl3 controls development and function of classical dendritic cells required for resistance to Toxoplasma gondii. | PLoS Pathog | 2022 | 36318581 | PubTator, text mining | PubMed |
| Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma. | Front Genet | 2022 | 36313455 | PubTator, text mining | PubMed |
| The liver-resident immune cell repertoire - A boon or a bane during machine perfusion? | Front Immunol | 2022 | 36311746 | PubTator, text mining | PubMed |
| Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications. | Nat Commun | 2022 | 36309526 | PubTator, text mining | PubMed |
| Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. | Clin Transl Med | 2022 | 36305631 | PubTator, text mining | PubMed |
| Biological effects of COVID-19 on lung cancer: Can we drive our decisions. | Front Oncol | 2022 | 36300087 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/papers?page=20